Marco Colleoni

Istituti di Ricovero e Cura a Carattere Scientifico

Also affiliated with European Institute of Oncology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer”.

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2212856

N/A

4.5DataRank · unranked

216 citations

Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni +34 more

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

The Breast(2025)10.1016/j.breast.2025.104547

N/A

0.165DataRank · unranked

2 citations

Samuel M. Niman, Ann H. Partridge, Daniela Diego, Roswitha Kammler, Monica Ruggeri +31 more

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women

Annals of Oncology(2023)10.1016/j.annonc.2023.01.009

N/A

0DataRank · unranked

48 citations

Giuseppe Viale, Serena Nik‐Zainal, Peter Savas, Roswitha Kammler, Patrizia Dell’Orto +33 more

Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy

Journal of Clinical Oncology(2024)10.1200/jco.23.02292

N/A

0DataRank · unranked

27 citations

Samuel M. Niman, Ann H. Partridge, Isabelle Demeestere, Monica Ruggeri, Marco Colleoni +31 more

Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group

Cancer Treatment Reviews(2025)10.1016/j.ctrv.2025.103001

N/A

0DataRank · unranked

13 citations

Sherry Shen, Carmen Criscitiello, Rita A. Mukhtar, Lauren A. Gamble, Elena Guerini‐Rocco +20 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

The Breast(2020)10.1016/j.breast.2020.05.012

N/A

0DataRank · unranked

18 citations

Samuel M. Niman, Olivia Pagani, Ann H. Partridge, Hatem A. Azim, Fedro A. Peccatori +6 more

Role of immunosuppressive JNK pathway in the tumor microenvironment among TNBC subtypes in IBCSG trial 22-00

iScience(2025)10.1016/j.isci.2025.112964

N/A

0DataRank · unranked

0 citations

Takashi Semba, Mattia Rediti, Daniel J. McGrail, Xuemei Xie, Xiaoping Wang +13 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00452-8

N/A

0DataRank · unranked

13 citations

Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer +15 more